Source: Annual Congress 2005 - Diffuse parenchymal lung diseases: experimental animal studies and case reports
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
V. V. Kraeva, E. A. Kogan, K. U. Reznikova, B. M. Kornev, V. V. Dengin, V. I. Ossipenko, E. N. Popova (Moscow, Russian Federation). Lung function and symptom improvement in patients with pulmonary alveolar proteinosis after whole lung lavage or N-acetylcysteine treatment. Eur Respir J 2005; 26: Suppl. 49, 623

Member's Comments

No comment yet.

Related content which might interest you: Determinants of protein concentration in whole lung lavage of patients with pulmonary alveolar proteinosis Source: Annual Congress 2009 - From genetics to clinics in diffuse parenchymal lung diseases Year: 2009 Whole lung lavage (WLL) for patients with pulmonary alveolar proteinosis Source: Eur Respir J 2004; 24: Suppl. 48, 670s Year: 2004 Whole lung lavage (WLL) in pulmonary alveolar proteinosis (PAP): long-term lung function follow-up Source: Eur Respir J 2001; 18: Suppl. 33, 220s Year: 2001 The benefits of whole lung lavage in pulmonary alveolar proteinosis Source: Eur Respir J 2004; 23: 503-505 Year: 2004 Long-term durable benefit after whole lung lavage in pulmonary alveolar proteinosis Source: Eur Respir J 2004; 23: 526-531 Year: 2004 KL-6 in whole lung lavage fluid of patients with pulmonary alveolar proteinosis Source: Annual Congress 2009 - Sarcoidosis and profiles of other diffuse parenchymal lung disease Year: 2009 Pulmonary alveolar proteinosis: failure of treatment by bronchoscopic lobar lavages and GM-CSF treatment in a child Source: Eur Respir J 2003; 22: Suppl. 45, 309s Year: 2003 Pulmonary alveolar proteinosis and long-term outcome after bronchopulmonary lavage Source: International Congress 2017 – Paediatric bronchology Year: 2017 Mini-whole lung lavage to treat pulmonary alveolar proteinosis (PAP) Source: Virtual Congress 2020 – Addressing unresolved questions in rare diffuse parenchymal lung diseases: interdisciplinary research is the key Year: 2020 Whole lung lavage with intermittent double lung ventilation: a new technique for managing pulmonary alveolar proteinosis Source: Eur Respir J 2004; 24: Suppl. 48, 91s Year: 2004 Whole lung lavage efficacy in pulmonary alveolar proteinosis (PAP) is influenced by the infusion volume? Source: International Congress 2015 – IIPs: orphan Year: 2015 Pulmonary alveolar proteinosis Source: Respipedia Article Year: 2017 The value of the whole lung lavage for patients with pulmonaryalveolar proteinosis Source: Annual Congress 2009 - Trends in bronchoscopy Year: 2009 Whole lung lavage therapy (WLL) of pulmonary alveolar proteinosis (PAP): A global survey of current practices and procedures Source: International Congress 2016 – Orphan diseases I Year: 2016 Efficacy of total lung lavage in pulmonary alveolar proteinosis: A multicenter international study of GELF Source: International Congress 2016 – Advancements in bronchoscopy Year: 2016 Early effect of whole lung lavage (WLL) on surfactant homeostasis in pulmonary alveolar proteinosis (PAP) Source: International Congress 2014 – ILDs: diagnostic and prognostic investigations Year: 2014 Idiopathic pulmonary alveolar proteinosis: GM CSF therapy and whole lung lavage a case report Source: Eur Respir J 2003; 22: Suppl. 45, 44s Year: 2003 Pulmonary alveolar proteinosis (PAP) - clinical features and response to treatment by bronchofiberoscopic lobar lavage Source: Eur Respir J 2005; 26: Suppl. 49, 541s Year: 2005 Inhaled sargramostim and whole lung lavage (WLL) as therapy of autoimmune pulmonary alveolar proteinosis (aPAP) Source: International Congress 2016 – Orphan diseases I Year: 2016 Call for an international survey on therapeutic lavage for pulmonary alveolar proteinosis Source: Eur Respir J 2012; 39: 1049 Year: 2012